作者
Samantha Yeager, Daniela Abramovitz, Alicia Yolanda Harvey-Vera, Carlos F Vera, Angel Blake Algarin, Laramie Rae Smith, Gudelia Rangel, Irina Artamonova, Thomas Leroy Patterson, Angela Robertson Bazzi, Emma L Brugman, Steffanie Ann Strathdee
发表日期
2022/4/27
期刊
BMC Public Health
卷号
22
期号
1
页码范围
842
出版商
BioMed Central
简介
Background
People who inject drugs (PWID) are vulnerable to SARS-CoV-2 infection. We examined correlates of COVID-19 testing among PWID in the U.S.-Mexico border region and described encounters with services representing potential opportunities (i.e., ‘touchpoints’) where COVID-19 testing could have been offered.
Methods
Between October, 2020 and September, 2021, participants aged ≥18 years from San Diego, California, USA and Tijuana, Baja California, Mexico who injected drugs within the last month completed surveys and SARS-CoV-2, HIV, and HCV serologic testing. Logistic regression identified factors associated with COVID-19 testing including potential touchpoints, comorbidities and COVID-19 related misinformation and disinformation.
Results
Of 583 PWID, 30.5% previously had a COVID-19 test. Of 172 PWID who tested SARS-CoV-2 seropositive (30.1%), 50.3% encountered at least one …
学术搜索中的文章
S Yeager, D Abramovitz, AY Harvey-Vera, CF Vera… - BMC Public Health, 2022